TBX2 and prostate cancer: (2017) showed that Wnt signalling is an essential mediator of TBX2 in prostate cancer metastasis and that blocking the pathway through neutralising antibodies or a Wnt antagonist blocked TBX2‐induced invasion in prostate cancer cells [65, 66].